Liver Tumors in Pediatric Patients

Area of Science:

• Pediatric Oncology
• Hepatobiliary Malignancies
• Clinical Trials

Background:

• Hepatoblastoma and hepatocellular carcinoma are primary liver cancers in children.
• Previous treatment strategies lacked global standardization.
• Advances in risk stratification and staging were needed for international collaboration.

Purpose of the Study:

• To introduce the Pediatric Hepatic International Tumor Trial (PHITT).
• To describe the collaborative international framework of the PHITT.
• To highlight the foundational elements enabling this global trial.

Main Methods:

• The PHITT opened for international enrollment in 2018.
• It involves pediatric multicenter trial groups from North America, Europe, and the Far East.
• The trial is supported by a unified global risk stratification system for hepatoblastoma, an international histopathologic consensus classification, and a revised staging system (PRETEXT).

Main Results:

• The trial represents a significant advancement in pediatric liver cancer care.
• It facilitates a unified approach to diagnosis and treatment planning.
• International collaboration is established for pediatric liver tumor research.

Conclusions:

• The PHITT signifies a new era in managing pediatric liver tumors.
• Standardized risk stratification and staging are crucial for international cooperative trials.
• This collaborative effort aims to improve outcomes for children with hepatoblastoma and hepatocellular carcinoma.